JP2024523445A5 - - Google Patents

Info

Publication number
JP2024523445A5
JP2024523445A5 JP2023578738A JP2023578738A JP2024523445A5 JP 2024523445 A5 JP2024523445 A5 JP 2024523445A5 JP 2023578738 A JP2023578738 A JP 2023578738A JP 2023578738 A JP2023578738 A JP 2023578738A JP 2024523445 A5 JP2024523445 A5 JP 2024523445A5
Authority
JP
Japan
Prior art keywords
nucleic acid
seq
pharmaceutical
sequence
aav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578738A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523445A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/066922 external-priority patent/WO2022268835A1/en
Publication of JP2024523445A publication Critical patent/JP2024523445A/ja
Publication of JP2024523445A5 publication Critical patent/JP2024523445A5/ja
Pending legal-status Critical Current

Links

JP2023578738A 2021-06-21 2022-06-21 α-シヌクレインをサイレンシングするための遺伝子構築物及びその使用 Pending JP2024523445A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21180613.8 2021-06-21
EP21180613 2021-06-21
EP22168018.4 2022-04-12
EP22168018 2022-04-12
PCT/EP2022/066922 WO2022268835A1 (en) 2021-06-21 2022-06-21 Gene constructs for silencing alpha-synuclein and uses thereof

Publications (2)

Publication Number Publication Date
JP2024523445A JP2024523445A (ja) 2024-06-28
JP2024523445A5 true JP2024523445A5 (cg-RX-API-DMAC7.html) 2025-06-30

Family

ID=82358408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578738A Pending JP2024523445A (ja) 2021-06-21 2022-06-21 α-シヌクレインをサイレンシングするための遺伝子構築物及びその使用

Country Status (4)

Country Link
US (1) US20250382611A1 (cg-RX-API-DMAC7.html)
EP (1) EP4359525A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024523445A (cg-RX-API-DMAC7.html)
WO (1) WO2022268835A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4774387A1 (en) 2023-09-04 2026-07-15 uniQure biopharma B.V. Novel neurotropic recombinant adeno-associated virus particles
WO2025078606A1 (en) * 2023-10-11 2025-04-17 Uniqure Biopharma B.V. Further novel systems for nucleic acid regulation
CN122341734A (zh) * 2023-10-11 2026-07-03 优尼科生物制药有限公司 重复扩增障碍中msh3的核酸调节

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004794A2 (en) * 2003-06-09 2005-01-20 Alnylam Pharmaceuticals Inc. Method of treating neurodegenerative disease
WO2005045034A2 (en) * 2003-10-23 2005-05-19 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA)
EP1799826B1 (en) * 2004-09-29 2009-08-12 Children's Memorial Hospital siRNA-MEDIATED GENE SILENCING OF ALPHA SYNUCLEIN
PT3272872T (pt) 2005-10-20 2020-06-26 Uniqure Ip Bv Vetores aav melhorados produzidos em células de insetos
WO2007148971A2 (en) 2006-06-21 2007-12-27 Amsterdam Molecular Therapeutics B.V. Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
HUE029744T2 (en) 2007-07-26 2017-04-28 Uniqure Ip Bv Baculoviral vectors comprising repeated coding sequences with differential codon biases
US20090176729A1 (en) * 2007-12-14 2009-07-09 Alnylam Pharmaceuticals, Inc. Method of treating neurodegenerative disease
AU2009215987B2 (en) 2008-02-19 2015-01-22 Uniqure Ip B.V. Optimisation of expression of parvoviral rep and cap proteins in insect cells
WO2010129791A1 (en) * 2009-05-06 2010-11-11 University Of Medicine And Dentistry Of New Jersey Rna targeting in alpha-synucleinopathies
WO2011122950A1 (en) 2010-04-01 2011-10-06 Amsterdam Molecular Therapeutics (Amt) Ip B.V. Monomeric duplex aav vectors
PT2561078T (pt) * 2010-04-23 2018-12-03 Cold Spring Harbor Laboratory Sharn com uma conceção estrutural inovadora
EP3521451A1 (en) * 2010-11-17 2019-08-07 Ionis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
JP6198278B2 (ja) 2011-09-08 2017-09-20 ユニキュアー アイピー ビー.ブイ. Aav調製物からの混入ウイルスの除去
AU2015370903B2 (en) 2014-12-24 2021-06-17 Uniqure Ip B.V. RNAi induced huntingtin gene suppression
US11046955B2 (en) * 2015-04-24 2021-06-29 University Of Massachusetts Modified AAV constructs and uses thereof
MX2020004005A (es) * 2017-10-03 2020-10-05 Prevail Therapeutics Inc Terapias genicas para los trastornos lisosomales.
TW202509215A (zh) * 2018-08-03 2025-03-01 美商健臻公司 針對α-突觸核蛋白的變體RNAi
WO2020104295A1 (en) * 2018-11-19 2020-05-28 Uniqure Ip B.V. Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3
AU2019385638A1 (en) * 2018-11-19 2021-06-03 Uniqure Ip B.V. A companion diagnostic to monitor the effects of gene therapy
US11827880B2 (en) * 2019-12-02 2023-11-28 Shape Therapeutics Inc. Therapeutic editing

Similar Documents

Publication Publication Date Title
US12577588B2 (en) AAV capsids with increased tropism to brain tissue
US12419969B2 (en) AAV capsid variants and uses thereof
JP2025507338A5 (cg-RX-API-DMAC7.html)
JP2021534809A (ja) Aavカプシドの向性の再指向化
JP2023527354A5 (cg-RX-API-DMAC7.html)
AU2023217698A1 (en) Aav capsid variants and uses thereof
JP7616995B2 (ja) 神経変性疾患のための遺伝子治療
JP2021522273A5 (cg-RX-API-DMAC7.html)
WO2020028751A2 (en) Aav variants with enhanced tropism
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
WO2020223280A1 (en) Aav variants with enhanced tropism
JP2024513949A5 (cg-RX-API-DMAC7.html)
US20250215453A1 (en) Aav capsid variants and uses thereof
JP2022531809A5 (cg-RX-API-DMAC7.html)
JP2024539123A5 (cg-RX-API-DMAC7.html)
US20250388626A1 (en) Aav capsid variants and uses thereof
JP2024543211A5 (cg-RX-API-DMAC7.html)
JP2025513066A5 (cg-RX-API-DMAC7.html)
WO2025038430A1 (en) Aav capsid variants and uses thereof
JP2025512061A5 (cg-RX-API-DMAC7.html)
JP2025512709A5 (cg-RX-API-DMAC7.html)
JP2025509262A5 (cg-RX-API-DMAC7.html)
WO2025147436A1 (en) Aav capsid variants and uses thereof
JP2023545384A5 (cg-RX-API-DMAC7.html)
WO2025080847A1 (en) Therapeutic regulation of scn1a splicing